Eric Pulier has produced innovations in just about every single field of software development imaginable. He created remote desktop software, he has created APIs, and he has even worked in communications, Over the years he has gathered dozens of patents and he has made his name synonymous with quality. There are others who have similar levels of patent holdings, but none are quite as versatile as he has proved to be in his decades of business.
He Has Used Software To Help Charities
Pulier is exceptionally wealthy but he doesn’t allow that to get in the way of his social conscience. He has made an effort since the 90s to us this talents to advance the world through philanthropy. Particularly, he has sough to help those who are unable to provide for themselves because of disease and other factors beyond their control. During the 90s he helped the Starbright Foundation create the Starbright World social network. This social network, the first private social network in the world, continues to serve children around the world in need of a connection to others.
He Has Served His Country With His Skills
Beyond acts of philanthropy he has also used his talents to help the government when the government is in need of assistance. One such example of Pulier’s work is the work he did for Bill Clinton. During his presidency Bill Clinton wanted to create an exhibit to display what future technology might bring people. This is where he got the idea for the “Bridge To The 21st Century“. He hired Eric Pulier to create this exhibit and Pulier delivered. This exhibit is still remembered to this day for the creative vision it portrayed of our future.
About Eric Pulier
Eric Pulier is a software develop best known for the work he did in the 90s. With a net worth in the hundreds of Millions he has made a name for himself as one of the most successful software developers around. Due to his success he is able to perform philanthropic deeds for many charities.
Scott M. Rocklage, PhD is a Managing Partner at the venture capital firm 5 AM Ventures. He came to the company with over 30 years of experience in the field of healthcare management. Additionally, he is the Board Chairman for healthcare company Rennovia, Kinestral and Cidara. of He earned his Bachelor’s Degree in Chemistry from the University of California, Berkeley. He went on to attend MIT where he earned his PhD in Chemistry.
During his healthcare career, Dr. Rocklage served at the executive level of a number of companies. He has been the Executive Chairman of Ilypsa and the Board Chairman at Relypsa as well as Novira. He has also been the Chief Executive Officer and President of Cubist Pharmaceuticals. In addition to serving as the President and CEO of Nycomed Salutar he has worked in research and development at Salutar and Catalytica. Dr. Rocklage has led three drugs to FDA approval; Cubicin, Teslascan, and Omniscan. He holds over 30 patents that he is named either the inventor or co-inventor on.
At 5 AM Ventures, Dr. Rocklage provides his expertise on the life science companies that they are looking to invest in as well as their ongoing support of these new ventures. The company looks for those that are developing new approaches in the diagnosing, prevention, and curing of a variety of medical conditions. In addition to investing in these companies, 5 AM Ventures provides ongoing support by helping to develop the company’s strategy, business development, the recruitment of managers, and often serve as board members for these nascent firms.
In 2016 Dr. Scott Rocklage was approached by a former Department Head of Chemistry at MIT on if he would help provide funds for some of the needs that it faced. As a result of this interaction Dr. Rocklage and his wife, Patty, gave the department at MIT a large contribution that resulted in the renovations of the Lester Wolfe Professor of Chemistry nanochemistry lab space as well as the Moungi Bawendi nanotechnology lab space. A plaque has now been mounted in their honor inside of the lab’s vestibule.
Eric Lefkofsky is a billionaire entrepreneur who not only financially endows philanthropic endeavors but also builds good works into his business models. Currently residing in Glencoe, Illinois, Mr. Lefkofsky focuses a majority of his efforts in the Chicago area. His corporate reach is, however, global and substantial.
Mr. Lefkofsky concentrates his endowments on education, arts and culture, human rights, healthcare, and medical research organizations. In the Chicago area, he is Chairman of the Board of Trustees of the Steppenwolf Theatre Company and a Trustee of Lurie Children’s Hospital of Chicago, The Art Institute of Chicago, The Museum of Science and Industry and World Business Chicago according to his LinkedIn profile. Outside Chicago, Mr. Lefkofsky donates to several hospitals, associations and education programs according to the Inside Philanthropy Guide. He is a signatory of the Giving Pledge, a directive established by Mr. and Mrs. Bill Gates and Warren Buffett for billionaires committed to donating most of their wealth to charity. Additionally, Mr. Lefkofsky operates the Lefkofsky Family Foundation to further support scientific and educational initiatives aimed at enhancing the quality of life. See also www.crunchbase.com.
Mr. Eric Lefkofsky’s generous nature extends beyond nonprofit foundations into the companies he builds. Three examples are Uptake, Lightbank and Tempus, Inc. Uptake benefits global start-up companies by supplying cross-industry data useful in designing and decision making. This extensive, comprehensive database leads to safer, more productive, more efficient companies with less asset loss and less chance of catastrophic failure. The Lightbank.com is a venture capital firm that specializes in backing disruptive technology. As defined by McKinsey and Company, disruptive technology involves innovation that significantly changes or replaces conventional methods for the better. For example, robotic surgery and sustainable energy production are disruptive technologies. Finally, Tempus is a technology company serving the cancer treatment field by amassing a comprehensive, cohesive database of treatments cross-referenced with outcomes, patient medical histories and even genomic sequencing services. This database is available in real-time to assist physicians in choosing and tailoring treatment options for each patient. Check https://www.tempus.com/about-us/
Mr. Eric Lefkofsky shares his vision with his wife, Liz, and his longtime business partner Brad Keywell.